News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 


MSNZ welcomes consultation period for Tysabri and Gilenya

Media release (8 August 2014)


MSNZ welcomes beginning of consultation period for Tysabri and Gilenya as proposed new first-line treatments for relapsing remitting forms of Multiple Sclerosis.

The Multiple Sclerosis Society of New Zealand (MSNZ) welcomes PHARMAC’s release of a consultation document today that proposes Natalizumab (Tysabri)and Fingolimod (Gilenya) as potential new first-line treatments for relapsing, remitting forms of MS.

PHARMAC is seeking feedback on a funding proposal involving five treatments for multiple sclerosis (MS), including these two new treatments. It is also seeking feedback on potential changes to the currently funded treatments Avonex, Betaferon and Copaxone.

In February, PTAC (the Pharmaceutical Technical Advisory Committee) recommended to PHARMAC that these new treatments be funded as new first-line treatments.

“It has been a long process to get to this point but PHARMAC’s announcement is a positive step,” says MSNZ spokesman Neil Woodhams. “Relapsing Remitting MS is one of four types of MS, affecting the highest percentage of patients. These new treatments, if accepted by PHARMAC, will be given as soon after diagnosis as possible, to patients fitting within the criteria. This is a great start for all those who will benefit from these treatments.”

Subject to a positive outcome from its consultation process, PHARMAC has suggested that Natalizumab and Fingolimod could be listed on the Hospital Medications List by 1 November 2014 and that changes to the restrictions around access to treatments that are currently funded could also be made by that date.

“This is not the end of the process,” says Mr Woodhams. “The next stage of consultation begins today. We recommend that interested parties read the consultation documents carefully as there are restrictions on the access to these treatments and changes that will be made to the currently-funded treatments.”

Submissions on PHARMAC’s consultation document close on 29 August, 2014.

“MSNZ would like to thank everyone involved in the Patients’ Steering Group, the MS Community, neurologists and supporters who have helped to highlight the importance of funding these new first-line treatments. MSNZ has been overwhelmed with the support and commitment shown to date and we urge supporters to maintain their level of engagement during the next stage of the process and beyond.”


More information about the consultation documents:
For more information visit the PHARMAC website:
www.pharmac.health.nz/news/consultation-2014-08-07-mstreatments/

Details of the proposal, including proposed funding access criteria, and some background information can be found at:
www.pharmac.health.nz/assets/consultation-2014-08-07-mstreatments.pdf

Please note: The fingolimod component of this proposal is dependent on a multi-product provisional agreement with Novartis, for a number of other products including fingolimod, being approved. PHARMAC are consulting on the Novartis multiproduct proposal separately, see PHARMAC’s website at: www.pharmac.health.nz/news/consultation-2014-08-07-multiproduct.
www.pharmac.health.nz/assets/consultation-2014-08-07-multiproduct.pdf

About MSNZ:
For more information about MSNZ please email info@msnz.org.nz or call 0800 MS LINE (67 54 63).

© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

Maori Language Commission: Te Wiki O Te Reo Māori 2015

The theme for Māori Language Week 27 July – 2 August 2015 is ‘Whāngaihia te Reo ki ngā Mātua’ ‘Nurture the language in parents’. It aims to encourage and support every day Māori language use for parents and caregivers with children” says Acting Chief Executive Tuehu Harris.. More>>

ALSO:

Live Music: Earl Sweatshirt Plays To Sold Out Bodega

The hyped sell-out crowd had already packed themselves as close as they could get to the stage before Earl came on. The smell of weed, sweat and beer filled Bodega – more debauched sauna than bar by this point. When he arrived on stage the screaming ... More>>

Scoop Review Of Books: Māori Past And Present

In its heft, exceptional production values and omniscient tone, Tangata Whenua looms a bit like a Bentley in a downtown parking building – a distinguished and doomed reminder of a former literary age. More>>

Photos: Cosplay And Wrestling At Armageddon Wellington

Armageddon Expo wrapped on Sunday with wrestling and a cosplay (costume play) competition. The gathered nerds were in good spirits with the Westpac stadium turning into a liminal space of fantasy, sci-fi and anime. More>>

John McBeth: Israel Dagg Form Timely

The unfortunate injuries to Waisake Naholo and Cory Jane at the weekend emphasised the importance of Israel Dagg in this Rugby World Cup season. More>>

ALSO:

Werewolf: Point Break - Lawyers Don’t Surf

Has there ever been a more ridiculous and brilliant name for an FBI agent in the movies than Johnny Utah and has there ever been a more appropriately beautiful, dim and earnest young man to play him than the Keanu Reeves of Point Break? More>>

ALSO:

Werewolf: Talent To Burn

America's Got Talent: The show was filmed in one of a collection of enormous empty hangars once used by Northrop Grumman to manufacture jets and spacecraft... the set itself was but a fragment of glossy illusion in an empty warehouse with rows of cheap seating, wads of gaffer tape, and cameras on bare concrete floors. More>>

ALSO:

Get More From Scoop

 
 

LATEST HEADLINES

 
 
 
 
Health
Search Scoop  
 
 
Powered by Vodafone
NZ independent news